Oravel Stays Ltd, which operates travel tech firm and brand OYO, on Wednesday said it will refile its draft public listing application by the middle of next month.

Earlier this month capital markets regulator Sebi had asked the company to refile the draft initial public offering (IPO) papers with certain updates.

Drugmaker Cipla said on Wednesday it has launched a diagnostic device to test for diabetes, infectious diseases, cardiac markers, thyroid function and other conditions.

Cippoint will allow healthcare professionals to get test results in 3 to 15 minutes, enabling a faster clinical decision-making process. The device has an automated system and is user-friendly and it can be used in remote areas or mobile vans, said the company.

Amazon has reclaimed the top spot as the world’s most valuable brand despite its brand value falling 15 per cent this year from $350.3 billion to $299.3 billion, said a new report.

According to brand valuation consultancy Brand Finance’s report, “Global 500 2023”, while Amazon is back at No 1, its brand value has fallen by over $50 billion this year, with its rating slipping from AAA+ to AAA. This is as consumers evaluate it more harshly in the post-pandemic world.

Prime Minister Narendra Modi, on the second and final day of the the party's National Executive meeting on Tuesday, made several important points to BJP leaders to strengthen the party in view of the Lok Sabha elections next year, sources said.

According to the source, PM Modi emphasised on meeting people of all religions and asked party leaders to go to universities, churches, etc to meet and interact with people.

Wealth management firm 360 ONE has acquired a controlling stake in Mumbai Angels, an angel investment platform focused on early-stage start-ups. With this acquisition, the investing platform has also announced the launch of two new funds – Category 1 Venture Capital Fund - Angel Fund, and Category 1 Venture Capital Fund (VCF).

The former is a Rs 1,000 crore fund, with a green shoe option of an additional Rs 200 crore.

Ahead of Republic Day, Delhi Police is hunting for four other terror suspects, besides the two who were arrested last week from the Jahangirpuri area in the national capital, sources said on Tuesday.

According to the Delhi Police Special Cell sources, the terror suspects recieved weapons from Pakistan through the drop-dead method and were in touch with their handlers on the other side of the border through a social media app.

Shares of Nykaa's parent company - FSN E-Commerce Ventures - hit a new all-time low of Rs 132.55, down 5.5 per cent on the BSE in Tuesday’s intra-day trade, in an otherwise firm market. In the past two days, the stock has plunged 10 per cent, while it has slipped 15 per cent in the past four trading days.

At 11:07 AM, Nykaa was quoting 4.5 per cent lower at Rs 133.90, as compared to 0.51 per cent rise in the S&P BSE Sensex.

Tata Motors, which dominates the electric passenger vehicles space in India with a market share of around 85 per cent, is likely to face challenges this year from two Chinese companies looking to acquire one-third of the domestic EV market, The Financial Express reported on Tuesday.

The Chinese-owned British brand MG Motor and China's biggest EV maker BYD are ramping up their operations to dent the Indian giant's dominance in the emerging sector.

In a bid to expand the cloud infrastructure to cater to the growing demand in India, tech giant Google has signed a deal with Raiden Infotech India to pick up a data centre spread over 381,000 sq ft in Navi Mumbai through a lease of 28 years, a report by The Economic Times said.

Alphabet Inc's company will pay Rs 1,144 crore over first 10 years with a rental escalataion of 1.75 per cent every 12 years. Earlier, it had acquired a 464,000 sq ft facility at Adani Centre in Noida on a 10-year lease.

Pharmaceutical firm Lupin on Monday said it has received tentative approval from the US health regulator to market its generic version of Dolutegravir and Rilpivirine tablets used in treatment of HIV infection.

The tentative approval granted by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) of Dolutegravir and Rilpivirine tablets of strength 50 mg/25 mg, Lupin said in a regulatory filing.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.